$CNTN News

Canton Strategic Holdings, Inc. - Common Stock Q1 EPS $(0.23) Up From $(0.99) YoY

Tharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in Webinar

Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update

Tharimmune Rebrands In Alignment With Its Digital Asset Treasury Strategy. Effective Wednesday, February 18, The Company Will Change Its Name To Canton Strategic And Will Begin Trading On Nasdaq Under The Ticker Symbol CNTN

Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

Tharimmune Elects Mark Wendland As Chairman Of The Board, Succeeding Vincent LoPriore; Names Angela Radkowski COO

Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost

The Canton Network, Its Coin, And Where It Might Be In 8 Years

Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization

Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Tharimmune Prices $55M Common Shares, Pre-Funded Warrants Offering

Tharimmune Receives Nasdaq Noncompliance Notification

Tharimmune Files For $2B Mixed Shelf Offering

Tharimmune Appoints Jacob Asbury As CFO, Effective Immediately

Tharimmune Receives FDA Feedback On TH104 Prophylaxis Program Against Respiratory Depression From Fentanyl And Ultrapotent Opioids; FDA Concurred With Co.'s Proposed Modeling Plan

On Nov 7, Tharimmune Appointed Sireesh Appajosyula As Interim CFO

Tharimmune Entered ATM Sales Agreement Worth Up To $64.9M

Tharimmune shares are trading higher after the company announced it entered into a $540 million private placement to fund the Canton Network blockchain strategy.